With decades of experience in leading biopharmaceutical companies, Ares can provide strategy and management consulting services to companies throughout the industry.
Having access to a wide range of pharmaceutical assets; from new molecular entities in early stage development, to next-gen biosimilars and to state of the art manufacturing sites, Ares can advise buy/sell sides and also propose such leads to its clients.
With respect to the deep expertise in all areas of product development, from early stage to clinical development, Ares can advise best practices strategies in the field to its clients and the tools and the network CROs/CDMOs/Manufacturers/World-class regulatory experts to execute.
Having a global network of c-suite executives and owners of biopharmaceutical manufacturers and commercialization partners, and the world-class expertise in BD&L operation, can empower Ares's clients to unlock their potential in the international markets.